Frequent activating mutations of FGFR3 in human bladder and cervix carcinomas

This publication has 17 references indexed in Scilit:

• A mouse model for achondroplasia produced by targeting fibroblast growth factor receptor 3
  Proceedings of the National Academy of Sciences, 1999
• A Novel Skeletal Dysplasia with Developmental Delay and Acanthosis Nigricans Is Caused by a Lys650Met Mutation in the Fibroblast Growth Factor Receptor 3 Gene
  American Journal of Human Genetics, 1999
• A Lys644Glu substitution in fibroblast growth factor receptor 3 (FGFR3) causes dwarfism in mice by activation of STATs and ink4 cell cycle inhibitors
  Human Molecular Genetics, 1999
• The t(4;14) Translocation in Myeloma Dysregulates Both FGFR3and a Novel Gene, MMSET, Resulting in IgH/MMSET Hybrid Transcripts
  Blood, 1998
• WHSC1, a 90 kb SET Domain-Containing Gene, Expressed in Early Development and Homologous to a Drosophila Dysmorphy Gene Maps in the Wolf-Hirschhorn Syndrome Critical Region and is Fused to IgH in t(1;14) Multiple Myeloma
  Human Molecular Genetics, 1998
• Frequent translocation t(4;14)(p16.3;q32.3) in multiple myeloma is associated with increased expression and activating mutations of fibroblast growth factor receptor 3
  Nature Genetics, 1997
• FGFR activation in skeletal disorders: Too much of a good thing
  Trends in Genetics, 1997
• Graded activation of fibroblast growth factor receptor 3 by mutations causing achondroplasia and thanatophoric dysplasia
  Nature Genetics, 1996
• Skeletal overgrowth and deafness in mice lacking fibroblast growth factor receptor 3
  Nature Genetics, 1996
• Fibroblast Growth Factor Receptor 3 Is a Negative Regulator of Bone Growth
  Cell, 1996